Opus Capital Group, LLC Gsk PLC Transaction History

Opus Capital Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 08, 2019	SELL	$39.4 - $42.7 $341,598 - $370,209	-8,670 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$39.75 - $42.69 $46,110 - $49,520	-1,160 Reduced 11.8%	8,670 $348,000
Q1 2018 May 04, 2018	BUY	$36.18 - $40.15 $355,649 - $394,674	9,830 New	9,830 $384,000
Q4 2017 Feb 02, 2018	SELL	$35.34 - $41.9 $347,038 - $411,458	-9,820 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$39.44 - $41.55 $387,300 - $408,021	9,820	9,820 $399,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $74.8B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Opus Capital Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Opus Capital Group, LLC with notifications on news.